These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1786387)

  • 1. [Changes in glutathione-S-transferase activity during induction of resistance of leukemia P 388 and Ehrlich ascitic tumor cells to doxorubicin].
    Donenko FV; Kabieva AO; Borovkova NB; Moroz LV
    Biull Eksp Biol Med; 1991 Aug; 112(8):188-90. PubMed ID: 1786387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of inhibitors of glutathione and glutathione transferase for overcoming resistance of tumor to cytostatics in an in vivo system].
    Donenko FV; Sitdikova SM; Kabieva AO; Polotskiĭ BE; Machaladze ZO; Davydov MI; Moroz LV
    Biull Eksp Biol Med; 1995 Feb; 119(2):212-4. PubMed ID: 7670058
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil effect on the accumulation of doxorubicin in the leukemia P388 cells with induced antibiotic resistance.
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
    Arch Geschwulstforsch; 1990; 60(2):129-32. PubMed ID: 2339961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S; Dutta P; Mookerjee A; Choudhuri SK
    Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer].
    Hu YP; Lin J; Wang QD; Yie QX; Zhang TM
    Yao Xue Xue Bao; 1993; 28(1):75-8. PubMed ID: 8328276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
    Noviello E; Allievi E; Russo P; Parodi S
    Anticancer Drug Des; 1997 Jun; 12(4):261-76. PubMed ID: 9199659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of finoptin on the accumulation of doxorubicin in leukemia P388 cells with induced resistance to the antibiotic].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
    Biull Eksp Biol Med; 1989 Dec; 108(12):714-6. PubMed ID: 2634447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menadione reduced doxorubicin resistance in Ehrlich ascites carcinoma cells in vitro.
    Xu CJ; Zhang Y; Wang J; Zhang TM
    Zhongguo Yao Li Xue Bao; 1998 May; 19(3):273-6. PubMed ID: 10375743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R; Dasdia T; Galatulas I; Zunino F
    Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
    Mestdagh N; Pommery N; Saucier JM; Hecquet B; Fournier C; Slomianny C; Teissier E; Hénichart JP
    Anticancer Res; 1994; 14(3A):869-74. PubMed ID: 7915509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
    Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
    Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agents.
    Pasquinelli P; Petrini M; Mattii L; Galimberti S; Saviozzi M; Malvaldi G
    J Environ Pathol Toxicol Oncol; 1993; 12(4):193-7. PubMed ID: 8189374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro mechanisms of drug resistance in a rat mammary carcinoma model.
    Schecter RL; Woo A; Duong M; Batist G
    Cancer Res; 1991 Mar; 51(5):1434-42. PubMed ID: 1997182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
    Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin.
    Crescimanno M; D'Alessandro N; Armata MG; Toulmond S; Tapiero H
    Anticancer Res; 1991; 11(2):901-3. PubMed ID: 2064348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
    Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.